AMG 794, a Claudin 6-targeted half-life extended (HLE) bispecific T cell engager (BITE®) molecule for non-small cell lung cancer and epithelial ovarian cancer.

被引:0
|
作者
Pham, Elizabeth [1 ]
Henn, Anja [2 ]
Sable, Beate [3 ]
Wahl, Joachim [2 ]
Conner, Kip [1 ]
Matthes, Katja [2 ]
Gupta, Shivani [1 ]
Yabut, Rodolfo [1 ]
Aeffner, Famke [1 ]
Wilson, Kristin Lewis [1 ]
Anlahr, Jonas [2 ]
Dahlhoff, Christoph [2 ]
Kale, Vijay [1 ]
Friedrich, Matthias [2 ]
Raum, Tobias [2 ]
Kufer, Peter [2 ]
Coxon, Angela [3 ]
Stienen, Sabine [2 ]
Bailis, Julie M. [1 ]
机构
[1] Amgen Inc, San Francisco, CA USA
[2] Amgen Res Munich GmbH, Munich, Germany
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5202
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Association of the T-cell receptor landscape with survival in non-small cell lung cancer.
    Reuben, Alexandre
    Gittelman, Rachel
    Zhang, Jiexin
    Quek, Kelly
    Vence, Luis M.
    Behrens, Carmen
    Chen, Runzhe
    Fujimoto, Junya
    Chow, Chi-Wan
    Wu, Xifeng
    Allison, James Patrick
    Sharma, Padmanee
    Zhang, Jianhua
    Lee, J. Jack
    Sepesi, Boris
    Gibbons, Don Lynn
    Heymach, John
    Futreal, Andrew
    Wistuba, Ignacio Ivan
    Zhang, Jianjun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [32] A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
    Dorff, Tanya
    Horvath, Lisa G.
    Autio, Karen
    Bernard-Tessier, Alice
    Rettig, Matthew B.
    Machiels, Jean-Pascal
    Bilen, Mehmet A.
    Lolkema, Martijn P.
    Adra, Nabil
    Rottey, Sylvie
    Greil, Richard
    Matsubara, Nobuaki
    Tan, Daniel S. W.
    Wong, Alvin
    Uemura, Hiroji
    Lemech, Charlotte
    Meran, Johannes
    Yu, Youfei
    Minocha, Mukul
    Mccomb, Mason
    Penny, Hweixian Leong
    Gupta, Vinita
    Hu, Xuguang
    Jurida, Gabor
    Kouros-Mehr, Hosein
    Janat-Amsbury, Margit M.
    Eggert, Tobias
    Tran, Ben
    CLINICAL CANCER RESEARCH, 2024, 30 (08) : 1488 - 1500
  • [33] DeLLphi-303: Phase Ib first-line combination study of tarlatamab, a DLL3-targeting half-life extended bispecific T-cell engager (HLE BiTE®), with carboplatin, etoposide, and PD-L1 inhibition in extensive stage small cell lung cancer (ES-SCLC)
    Gadgeel, S. M.
    Al-Mondhiry, J.
    Ahn, M-J.
    Kim, S-W.
    Paz-Ares, L.
    Prenen, H.
    Boyer, M.
    Bustamante Alvarez, J. G.
    Solomon, B.
    Huang, S.
    Minocha, M.
    Kistler, M.
    Sadraei, N. Hashemi
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1255 - S1255
  • [34] Phase I study evaluating safety and tolerability of AMG 910, a half-life extended bispecific T cell engager targeting claudin-18.2 (CLDN18.2) in gastric and gastroesophageal junction (G/GEJ) adenocarcinoma
    Lordick, F.
    Chao, J.
    Buxo, E.
    van Laarhoven, H. W. M.
    Lima, C. M. R.
    Lorenzen, S.
    Dayyani, F.
    Heinemann, V.
    Greil, R.
    Stienen, S.
    Shitara, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S928 - S929
  • [35] THE FUNCTIONAL ROLE OF EPITHELIAL CELL ADHESION MOLECULE (EPCAM) IN THE NON-SMALL CELL LUNG CANCER CELL LINES.
    Kondo, Masashi
    Hase, Tetsunari
    Sato, Mitsuo
    Kenya, Yoshida
    Takeyama, Yoshihiro
    Momen, Elshazley
    Sekido, Yoshitaka
    Gazdar, Adi F.
    Minna, John D.
    Hasegawa, Yoshinori
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S728 - S729
  • [36] Results of Extended Resection in T4 Non-Small Cell Lung Cancer
    Matsunaga, T.
    Suzuki, K.
    Takamochi, K.
    Oh, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S894 - S895
  • [37] Peptide targeting of the integrin αvβ6 for the treatment of non-small cell lung cancer.
    Li, Shunzi
    Lin, Mai
    Gray, Bethany P.
    Liu, Ying-Horng
    Wu, Lei
    Sun, Xiankai
    McGuire, Michael J.
    Brown, Kathlynn C.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3559S - 3560S
  • [38] Modeling epithelial plasticity-induced erlotinib resistance in non-small cell lung cancer.
    Wang, Hailun
    Cades, Jessica
    Yochum, Zachary
    Nugent, Katriana
    Rudin, Charles
    Burns, Timothy
    Phuoc Tran
    CANCER RESEARCH, 2018, 78 (10) : 77 - 78
  • [39] Breathing New Life Into Hypoxia-Targeted Therapies for Non-Small Cell Lung Cancer
    Lin, Steven H.
    Koong, Albert C.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (01):
  • [40] The utilization of chemotherapy and radiation at the end of life in individuals with metastatic non-small cell lung cancer.
    Stavas, Mark J.
    Martin, Sara F.
    Phillips, Sharon E.
    Perkins, Stephanie Mabry
    Shinohara, Eric T.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)